May 1, 2026
We’re pleased to highlight a recent achievement from our team: an image co-created by our scientists—a scanning electron micrograph of a Clostridioides difficile biofilm fragment—was selected as the cover art for a publication by the Texas Society for Microscopy. This work reflects our ongoing collaboration with University of Texas at Austin, where advanced imaging techniques are being applied to better understand complex infectious processes. The recognition underscores the depth of our scientific capabilities and our continued focus on applying innovative tools to advance programs targeting serious infections, including Clostridioides difficile.
Citation: Texas Society for Microscopy. (2026). Texas Journal of Microscopy, 57(1).
https://texas.microscopy.org/files/galleries/57-1Journal.pdf
Modern medicine should help patients feel better, not worse. At XBiotech, we believe in the Hippocratic principle of "do no harm." We believe this is inherent to the innovative True Human™ antibody medicines we are developing. True Human™ antibodies move beyond the idea that effective medicines must come with toxicity or harmful side effects.
By utilizing the body’s natural immune system, XBiotech develops therapies that help you heal and feel better.
